Jyothy Labs Limited
Quality (69/100) does the heavy lifting; momentum (23/100) is the drag.
Fair valueStocksWizard rates Jyothy Labs Limited a Sell, scoring 40/100 on our blended model. At ₹198.85 it trades above our blended DCF and relative-multiples fair value of ₹161.74, about 19% downside to that estimate — we read it as overvalued by 19%. On 22.1x trailing earnings it sits cheaper than the Consumer Defensive median of about 26.1x. The price is about 41% below its 52-week high of ₹337.93 and 5% above the low of ₹189.12. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹275.18 implies about 38% upside across 11 analysts. It clears 7 of 13 investability checks, with durability 69, valuation 41 and momentum 23 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹129.4.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-41.16% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 22.4%
- Pass: Low debt (D/E < 0.5): 0.03x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 8%
- Fail: Earnings growing: -12%
- Pass: Net margin ≥ 10%: 11.3%
- Pass: Current ratio > 1.5: 2.68
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 9.02
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter69.0%
- Institutions17.2%
- Public & other13.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (22.4%).
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 9.02.
Opportunities
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (3/9).
Threats
- Earnings contracting year on year.
About Jyothy Labs Limited
Jyothy Labs manufactures and markets fabric care, dishwashing, personal care, and household insecticide products across India and international markets. The company operates through five segments: Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others. Its Dishwashing segment produces dish wash bars, gels, liquids, scrubbers, and powders under the Pril and Exo brands.
Jyothy Labs Limited — frequently asked questions
Is Jyothy Labs Limited a buy, hold or sell?
StocksWizard currently rates Jyothy Labs Limited (JYOTHYLAB) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Jyothy Labs Limited's fair value?
Our blended DCF and relative-valuation model estimates Jyothy Labs Limited's fair value at about ₹161.74, versus a current price of ₹198.85 — roughly 19% downside. On that basis the stock looks overvalued by 19%.
Is Jyothy Labs Limited financially healthy?
Jyothy Labs Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Jyothy Labs Limited's share price performed?
Jyothy Labs Limited is down 24% over three months, and last traded at ₹198.85. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.